[go: up one dir, main page]

EE200100356A - Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui uudne antimikroobne ja antioksüdantne probiootikum - Google Patents

Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui uudne antimikroobne ja antioksüdantne probiootikum

Info

Publication number
EE200100356A
EE200100356A EEP200100356A EEP200100356A EE200100356A EE 200100356 A EE200100356 A EE 200100356A EE P200100356 A EEP200100356 A EE P200100356A EE P200100356 A EEP200100356 A EE P200100356A EE 200100356 A EE200100356 A EE 200100356A
Authority
EE
Estonia
Prior art keywords
strain
micro
probiotic
organism
lactobacillus fermentum
Prior art date
Application number
EEP200100356A
Other languages
English (en)
Inventor
Mikelsaar Marika
Zilmer Mihkel
Kullisaar Tiiu
Annuk Heidi
Songisepp Epp
Original Assignee
Tartu �likool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tartu �likool filed Critical Tartu �likool
Priority to EEP200100356A priority Critical patent/EE04580B1/et
Priority to PCT/EE2002/000006 priority patent/WO2003002131A1/en
Priority to RU2003137810/13A priority patent/RU2284354C2/ru
Priority to EP02742853A priority patent/EP1401457B1/en
Priority to DK02742853.1T priority patent/DK1401457T3/da
Priority to US10/481,713 priority patent/US7244424B2/en
Priority to DE60238482T priority patent/DE60238482D1/de
Priority to AT02742853T priority patent/ATE489959T1/de
Priority to ES02742853T priority patent/ES2356119T3/es
Publication of EE200100356A publication Critical patent/EE200100356A/et
Publication of EE04580B1 publication Critical patent/EE04580B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Fodder In General (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Medicinal Preparation (AREA)
EEP200100356A 2001-06-29 2001-06-29 Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum EE04580B1 (et)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EEP200100356A EE04580B1 (et) 2001-06-29 2001-06-29 Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
PCT/EE2002/000006 WO2003002131A1 (en) 2001-06-29 2002-06-21 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and antioxidative probiotic
RU2003137810/13A RU2284354C2 (ru) 2001-06-29 2002-06-21 Пробиотик
EP02742853A EP1401457B1 (en) 2001-06-29 2002-06-21 Strain of micro-organism lactobacillus fermentum me-3 as novel antioxidative probiotic
DK02742853.1T DK1401457T3 (da) 2001-06-29 2002-06-21 Stamme af mikroorganismen lactobacillus fermentum ME-3 som nyt antioxidativt probiotika
US10/481,713 US7244424B2 (en) 2001-06-29 2002-06-21 Strain of micro-organism Lactobacillus fermentum ME-3 as novel anti-microbiol and anti-oxidative probiotic
DE60238482T DE60238482D1 (de) 2001-06-29 2002-06-21 Mikroorganismus stamm lactobacillus fermentum me-3 als neues antioxidatives probiotisches mittel
AT02742853T ATE489959T1 (de) 2001-06-29 2002-06-21 Mikroorganismus stamm lactobacillus fermentum me- 3 als neues antioxidatives probiotisches mittel
ES02742853T ES2356119T3 (es) 2001-06-29 2002-06-21 Cepa del microorganismo lactobacillus fermentum me-3 como nuevo probiótico antioxidante.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EEP200100356A EE04580B1 (et) 2001-06-29 2001-06-29 Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum

Publications (2)

Publication Number Publication Date
EE200100356A true EE200100356A (et) 2003-02-17
EE04580B1 EE04580B1 (et) 2006-02-15

Family

ID=8161768

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100356A EE04580B1 (et) 2001-06-29 2001-06-29 Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum

Country Status (9)

Country Link
US (1) US7244424B2 (et)
EP (1) EP1401457B1 (et)
AT (1) ATE489959T1 (et)
DE (1) DE60238482D1 (et)
DK (1) DK1401457T3 (et)
EE (1) EE04580B1 (et)
ES (1) ES2356119T3 (et)
RU (1) RU2284354C2 (et)
WO (1) WO2003002131A1 (et)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040170617A1 (en) * 2000-06-05 2004-09-02 Finegold Sydney M. Method of treating diseases associated with abnormal gastrointestinal flora
MXPA05010696A (es) * 2003-04-02 2006-04-18 Axcan Pharma S A Cepa de lactobacillus fermentum y usos de la misma.
DE102005062731A1 (de) * 2005-12-22 2007-06-28 Organobalance Gmbh Neue Lactobacillus Stämme und deren Verwendung
TWI346554B (en) 2008-04-30 2011-08-11 Genmont Biotech Inc Lactobacillus isolates having anti-inflammatory activities and uses of the same
RU2412239C2 (ru) * 2008-08-15 2011-02-20 Учреждение Российской Академии медицинских наук Научно-исследовательский институт экспериментальной медицины Северо-Западного отделения РАМН /НИИЭМ СЗО РАМН/ ШТАММ Lactobacillus fermentum Z, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПРОИЗВОДСТВА ПРОБИОТИЧЕСКИХ МОЛОЧНОКИСЛЫХ ПРОДУКТОВ
RU2391395C1 (ru) * 2008-11-19 2010-06-10 Галина Геннадиевна Алехина ШТАММ Lactobacillus fermentum TS3-06, ИСПОЛЬЗУЕМЫЙ ДЛЯ ИЗГОТОВЛЕНИЯ БАКТЕРИАЛЬНЫХ ПРЕПАРАТОВ И ПРОИЗВОДСТВА ЖИДКОЙ МОЛОЧНОКИСЛОЙ ЗАКВАСКИ В КАЧЕСТВЕ ПРОДУКТА ПИТАНИЯ ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКОГО НАЗНАЧЕНИЯ
WO2011000879A2 (en) * 2009-06-30 2011-01-06 Chr. Hansen A/S A method for producing a fermented milk product
US8735089B2 (en) 2010-01-08 2014-05-27 Compagnie Gervais Danone Method for selecting bacteria with anti-oxidant action
EA024911B1 (ru) 2010-01-08 2016-11-30 Компани Жервэ Данон Лактобациллы с антиоксидантным действием
US9707207B2 (en) 2010-05-26 2017-07-18 The United States Of America As Represented By The Department Of Veterans Affairs Method for diagnosing, preventing, and treating neurological diseases
ES2600963T3 (es) * 2011-06-08 2017-02-13 Novozymes A/S Células/Cepas Lactobacillus secadas por pulverización y su uso contra Helicobacter pylori
RU2640920C2 (ru) * 2011-10-27 2018-01-12 Саликс Фармасьютикалз, ИНК. Электролитные слабительные средства
WO2013062034A1 (ja) * 2011-10-28 2013-05-02 株式会社明治 ナチュラルチーズおよびその製造方法
GB201223370D0 (en) * 2012-12-24 2013-02-06 Univ Tartu Method of treatment using lactobacillus fermentum ME-3
WO2015025072A1 (es) * 2013-08-23 2015-02-26 Consejo Superior De Investigaciones Científicas (Csic) Cepa probiótica de lactobacillus reuteri con actividad anti-helicobacter, producto probiótico o bioterapéutico que la comprende y uso del mismo
RS57471B1 (sr) * 2015-12-17 2018-09-28 Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerzitet U Beogradu Nova probiotička starter kultura za humanu i animalnu primenu
CN106967630B (zh) * 2016-12-01 2019-12-10 广东省微生物研究所（广东省微生物分析检测中心） 一种发酵乳杆菌及其应用
RU2705250C2 (ru) * 2018-02-05 2019-11-06 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Штамм Lactobacillus fermentum U-21, продуцирующий комплекс биологически активных веществ, осуществляющих нейтрализацию супероксид-аниона, индуцируемого химическими агентами
MX2021012552A (es) * 2019-04-16 2021-11-12 Locus Ip Co Llc Aditivos alimentarios emulsionantes basados en microbios.
RU2757118C2 (ru) * 2019-12-11 2021-10-11 Общество с ограниченной ответственностью "Фармабиотики" Применение клеток штамма Lactobacillus fermentum U-21 для предотвращения патологических изменений в тканях, вызванных оксидативным стрессом
KR102424594B1 (ko) * 2020-11-30 2022-07-25 파이토지노믹스 주식회사 항염 활성 및 유해 미생물에 대한 항균 활성을 가지는 락토바실러스 퍼멘텀 okbl-l.fe 1 균주 및 이의 용도
CN116574630B (zh) * 2023-01-31 2024-02-20 江苏省农业科学院 具有抑菌和抗氧化活性的乳杆菌、适用于秸秆青贮的复合微生物菌剂及其应用
CN116590175A (zh) * 2023-04-12 2023-08-15 吉林省中科特殊食品创新研究院有限公司 一种发酵乳杆菌elf041及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
RU2119796C1 (ru) * 1997-01-28 1998-10-10 Закрытое акционерное общество "БАКС" Комплексный пробиотический препарат для животных "бифитрилак"
KR100211529B1 (ko) 1997-04-28 1999-08-02 박원훈 유해 미생물 억제 활성을 갖는 신규 내산성 락토바실러스 속 미생물 및 이를 함유하는 가축용 생균활성제
IT1299070B1 (it) * 1998-04-10 2000-02-07 Proge Farm Srl Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
RU2133272C1 (ru) 1998-06-11 1999-07-20 Акционерное общество открытого типа "Биомед" им.И.И.Мечникова Штамм бактерии lactobacillus fermentum 90-ts-4(21), используемый для получения эубиотического препарата для применения в гинекологической практике
ID30071A (id) * 1998-12-11 2001-11-01 Urex Biotech Inc Pemberian oral lactobacillus untuk pengobatan dan pencegahan infeksi urogental

Also Published As

Publication number Publication date
DK1401457T3 (da) 2011-01-17
US20040151708A1 (en) 2004-08-05
ES2356119T3 (es) 2011-04-05
EE04580B1 (et) 2006-02-15
EP1401457A1 (en) 2004-03-31
RU2003137810A (ru) 2005-05-20
RU2284354C2 (ru) 2006-09-27
DE60238482D1 (de) 2011-01-13
ATE489959T1 (de) 2010-12-15
EP1401457B1 (en) 2010-12-01
WO2003002131B1 (en) 2003-03-06
US7244424B2 (en) 2007-07-17
WO2003002131A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
EE200100356A (et) Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui uudne antimikroobne ja antioksüdantne probiootikum
Aguilar-Galvez et al. Potential of tara (Caesalpinia spinosa) gallotannins and hydrolysates as natural antibacterial compounds
Piekarska-Radzik et al. Mutual influence of polyphenols and Lactobacillus spp. bacteria in food: A review
China et al. Antimicrobial activity of Sesbania grandiflora flower polyphenol extracts on some pathogenic bacteria and growth stimulatory effect on the probiotic organism Lactobacillus acidophilus
Abuelsaad et al. Antimicrobial and immunomodulating activities of hesperidin and ellagic acid against diarrheic Aeromonas hydrophila in a murine model
Singh et al. Antimicrobial activity of lemongrass (Cymbopogon citratus) oil against microbes of environmental, clinical and food origin
Ankolekar et al. Fermentation of whole apple juice using Lactobacillus acidophilus for potential dietary management of hyperglycemia, hypertension, and modulation of beneficial bacterial responses
ITRM20110475A1 (it) Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
Vaz et al. The antimicrobial effect of wine on Bacillus cereus in simulated gastro-intestinal conditions
Lim Purification and characterization of two bacteriocins from Lactobacillus brevis BK11 and Enterococcus faecalis BK61 showing anti-Helicobacter pylori activity
Viedma et al. Enhanced bactericidal effect of enterocin AS-48 in combination with high-intensity pulsed-electric field treatment against Salmonella enterica in apple juice
Haghighatafshar et al. The effect of bacteriocin isolated from Lactobacillus rhamnosus on Pseudomonas aeruginosa lipopolysaccharides
Manyi-Loh et al. Treatment of Helicobacter pylori infections: mitigating factors and prospective natural remedies
WO2019209086A1 (ko) 류코노스톡 메젠테로이드 균주 및 이의 용도
KR20120111091A (ko) 신규한 바실러스 아밀로리퀴페시언스의 배양물 및 그의 용도
KR101216729B1 (ko) 소나무로부터 항균 활성 및 항산화 활성을 가진 물질을 생산하는 방법
Rukayadi et al. Antibacterial and sporicidal activity of macelignan isolated from nutmeg (Myristica fragrans Houtt.) against Bacillus cereus
Nguyen et al. Biological Activities of Tetrodotoxin‐Producing Enterococcus faecium AD1 Isolated from Puffer Fishes
François et al. ANTIMICROBIAL ACTIVITY OF PROBIOTIC STRAIN Lactobacillus plantarum ISOLATED FROM †œSHA’ A†AND ASSESSMENT OF ITS VIABILITY IN LOCAL HONEY
Tesfaye et al. Inhibition of some foodborne pathogens by pure and mixed LAB cultures during fermentation and storage of ergo, a traditional Ethiopian fermented milk
Kadidrareddy et al. Therapeutic activity of conjugated linoleic acids synthesized by Lactobacillus plantarum
KR102065180B1 (ko) 클로스트리디오이데스 디피실레에 항균 활성을 갖는 락토바실러스 속 WiKim0092 균주 및 이를 포함하는 조성물
KR102065181B1 (ko) 클로스트리디오이데스 디피실레에 항균 활성을 갖는 락토바실러스 속 WiKim0093 균주 및 이를 포함하는 조성물
Saffari et al. Comparing the antimicrobial properties of pomegranate seed and peel extract with common antibiotics used on helicobacter pylori isolated from biopsies of patients referring to Kashan Shahid-Beheshti hospital
Ali et al. Immunomodulatory impact of herbs and probiotics in type 2 diabetic rat model

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231